INSIDER
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 43h ago
HOUSE PTR3h ago
SEC 13F3h ago
ROBINHOOD CHAIN3h ago
Public company

BIOABioAge Labs, Inc.

CIK 0001709941

EDGAR filingsOpen in network
Disclosed transactions4
Buys / sells0 / 1
Max Insider Score18
Connections3with evidence

BIOA · disclosed activity on price

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
5
FK
Fortney KristenDirector, Chief Executive Officer
BIOABioAge Labs, Inc.
Grant or award
A—
330.0K sh
Feb 17, 2026Feb 19, 2026
traded Feb 17, 2026
+2dSEC FORM 4

Evidence

Verified connections

  • In industryevidence
    Pharmaceuticals, devices & health servicesSEC SIC 2834 · Pharmaceutical Preparations · Nov 4, 2026
  • ← Insider ofevidence
    Morgen EricDirector, Chief Operating Officer · Feb 19, 2026
  • ← Insider ofevidence
    Fortney KristenDirector, Chief Executive Officer · Jan 15, 2026
9
ME
Morgen EricDirector, Chief Operating Officer
BIOABioAge Labs, Inc.
Grant or award
A
—
110.0K sh
Feb 17, 2026
Feb 19, 2026
traded Feb 17, 2026
+2d
SEC FORM 4

Evidence

9
ME
Morgen EricDirector, Chief Operating Officer
BIOABioAge Labs, Inc.
Grant or award
A—
12.5K sh
Feb 17, 2026Feb 19, 2026
traded Feb 17, 2026
+2dSEC FORM 4

Evidence

18
FK
Fortney KristenDirector, Chief Executive Officer
BIOABioAge Labs, Inc.
Open-market sale · 10b5-1 plan
SELL$4.22M
233.1K sh
Jan 13, 2026Jan 15, 2026
traded Jan 13, 2026
+2dSEC FORM 4

Evidence